{
  "first_published_at": "2013-08-07", 
  "original_url": "http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON300407", 
  "title": "Ondansetron for intravenous use: clarification of advice on new posology in patients age 65 years or older", 
  "tags": "{\"parsed_therapeutic\": [\"anaesthesia-intensive-care\", \"cancer\"], \"Audience:\": [\"Secondary care\"], \"Therapeutic area:\": [\"Anaesthesia and intensive care\", \"Cancer\"]}", 
  "_document_number": 57, 
  "label": null, 
  "icon": "http://www.mhra.gov.uk/home/images/MHRALook/img/dsu/dose_icon.png", 
  "therapeutic_area": [
    "anaesthesia-intensive-care", 
    "cancer"
  ], 
  "raw_html": "<div id=\"dsuArticleContent\">\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t<h1><a name=\"maincontent\" id=\"maincontent\"></a>Ondansetron for intravenous use: clarification of advice on new posology in patients age 65 years or older</h1>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<span class=\"ref\">Article date: August 2013</span> \r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t<!--We would like to make you aware that on July 24, 2013 we updated the information in the recent intravenous ondansetron posology article published in the July 2013 issue of the bulletin.-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t<!--<p>We would like to make you aware that on July 24, 2013 we updated the information in the recent intravenous ondansetron posology article published in the July 2013 issue of the bulletin. The article was updated to clarify that the new advice on dilution and administration in patients age 65 years or older refers only to the indication for prevention of chemotherapy-induced nausea and vomiting; there has been no change to the dosing, dilution, or administration instructions for the indication of postoperative nausea and vomiting.</p>\n\n<p>The article can be found <a target=\"_blank\" href=\"http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON296402\">here</a>. If you read, downloaded, or shared the article before the update on July 24, 2013, please revisit the article to ensure that you have the most up to date information.</p>\n\n<p>&#160;</p>\n\n<p><em>Article citation: Drug Safety Update vol 7 issue 1, August 2013: O3.</em></p>-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_BEGIN_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t\t<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t<p>We would like to make you aware that on July 24, 2013 we updated the information in the recent intravenous ondansetron posology article published in the July 2013 issue of the bulletin. The article was updated to clarify that the new advice on dilution and administration in patients age 65 years or older refers only to the indication for prevention of chemotherapy-induced nausea and vomiting; there has been no change to the dosing, dilution, or administration instructions for the indication of postoperative nausea and vomiting.</p>\n\n<p>The article can be found <a target=\"_blank\" href=\"http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON296402\">here</a>. If you read, downloaded, or shared the article before the update on July 24, 2013, please revisit the article to ensure that you have the most up to date information.</p>\n\n<p>&#160;</p>\n\n<p><em>Article citation: Drug Safety Update vol 7 issue 1, August 2013: O3.</em></p>\r\n\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_END_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t", 
  "date_of_article": "2013-08-01", 
  "date_last_modified": "2013-08-07", 
  "_assets": [], 
  "_item_id": 57, 
  "summary": "", 
  "body": "Article date: August 2013\n\nWe would like to make you aware that on July 24, 2013 we updated the information in the recent intravenous ondansetron posology article published in the July 2013 issue of the bulletin. The article was updated to clarify that the new advice on dilution and administration in patients age 65 years or older refers only to the indication for prevention of chemotherapy-induced nausea and vomiting; there has been no change to the dosing, dilution, or administration instructions for the indication of postoperative nausea and vomiting.\n\nThe article can be found [here](http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON296402). If you read, downloaded, or shared the article before the update on July 24, 2013, please revisit the article to ensure that you have the most up to date information.\n\nÂ \n\nArticle citation: Drug Safety Update vol 7 issue 1, August 2013: O3.\n"
}